Stockreport

Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal [Yahoo! Finance]

Altamira Therapeutics Ltd. - Common Shares  (CYTO) 
PDF the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced that highlights [Read more]